PUBLISHER: The Business Research Company | PRODUCT CODE: 1945445
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945445
A lab-on-skin microfluidic patch is a wearable device that combines microfluidic technology with a flexible, skin-adhering surface to continuously collect and analyze biofluids such as sweat, interstitial fluid, or tears. It operates as a compact laboratory on the skin, allowing real-time monitoring of physiological indicators such as electrolytes, glucose, lactate, and hydration levels for applications in health diagnostics, athletic performance, and personalized medicine.
The primary product types of lab-on-skin microfluidic patches include diagnostic patches, therapeutic patches, monitoring patches, and others. Diagnostic patches are skin-worn devices designed to detect and identify biomarkers such as ions, metabolites, or proteins that reflect disease states or physiological conditions. These patches are composed of materials such as polymer-based, paper-based, hybrid, and others. They are used in healthcare monitoring, disease diagnosis, drug delivery, sports and fitness, and other applications, serving end-users such as hospitals and clinics, homecare, research institutes, sports and fitness centers, and others.
Tariffs on microfluidic components and polymer substrates have affected the lab-on-skin microfluidic patch market, increasing costs of wearable diagnostic and therapeutic patches, especially in North America and Europe. However, this drives regional manufacturing initiatives and encourages innovation in alternative, cost-effective materials, supporting localized supply chains and market resilience.
The lab-on-skin microfluidic patch market research report is one of a series of new reports from The Business Research Company that provides lab-on-skin microfluidic patch market statistics, including lab-on-skin microfluidic patch industry global market size, regional shares, competitors with a lab-on-skin microfluidic patch market share, detailed lab-on-skin microfluidic patch market segments, market trends and opportunities, and any further data you may need to thrive in the lab-on-skin microfluidic patch industry. This lab-on-skin microfluidic patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The lab-on-skin microfluidic patch market size has grown exponentially in recent years. It will grow from $1.44 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to advances in microfluidics, wearable healthcare technology adoption, growth of sports analytics, increasing demand for non-invasive diagnostics, research in biofluid analysis.
The lab-on-skin microfluidic patch market size is expected to see rapid growth in the next few years. It will grow to $3.57 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to integration with AI-driven analytics, expansion in personalized medicine, remote patient monitoring growth, adoption in fitness & wellness sectors, technological innovation in patch materials. Major trends in the forecast period include continuous health monitoring, non-invasive diagnostics, personalized medicine devices, sports & fitness analytics, real-time biomarker detection.
The growing focus on personalized medicine is anticipated to drive the expansion of the lab-on-skin microfluidic patch market in the coming years. Personalized medicine is a healthcare approach that tailors medical treatment and preventive strategies to an individual's genetic, biomarker, and clinical profile to achieve better therapeutic outcomes. The increasing adoption of personalized medicine is supported by advances in genomics and biotechnology, which enable accurate diagnoses and targeted therapies that enhance treatment effectiveness and reduce unnecessary interventions. Lab-on-skin microfluidic patches contribute to this approach by continuously monitoring unique biomarkers, allowing real-time, individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization promoting personalized medicine, the US Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. Therefore, the rising emphasis on personalized medicine is propelling the growth of the lab-on-skin microfluidic patch market.
Companies operating in the lab-on-skin microfluidic patch market are increasingly developing advanced microfluidic technologies, such as sweat-sensing patches, to support real-time health monitoring and personalized diagnostics. A sweat-sensing patch is a wearable device that collects and analyzes sweat to track biomarkers, electrolytes, and other physiological indicators continuously. For example, in April 2024, Epicore Biosystems Inc., a US-based digital health company, launched Connected Hydration, a wearable microfluidic patch paired with a mobile application that helps industrial workers prevent dehydration and heat stress through continuous sweat and electrolyte monitoring. It offers real-time personalized hydration insights, vibration alerts, and AI-based recommendations to optimize fluid intake before fatigue or injury occurs. By integrating lab-on-skin sensing, cloud-based analytics, and a long-lasting battery system, Connected Hydration improves worker safety, productivity, and endurance in extreme heat environments across global industrial sectors.
In February 2024, Epicore Biosystems Inc. entered into a partnership with the US Anti-Doping Agency (USADA) to advance its microfluidic sweat patch technology for doping detection. This collaboration aims to enable non-invasive sweat biomarker collection for drug testing, improving the efficiency and convenience of anti-doping procedures while providing athletes with real-time health insights. The US Anti-Doping Agency is a US-based nonprofit and non-governmental organization responsible for implementing a comprehensive anti-doping program for ParaPan American sports in the United States.
Major companies operating in the lab-on-skin microfluidic patch market are Epicore Biosystems, Xsensio SA, Persperity Health Inc., Nutromics Pty Ltd., Biolinq Inc., Flow Bio Ltd., GraphWear Technologies Inc., GENTAG Inc., Nemaura Medical Inc., Kenzen Inc., Aline Inc., Eccrine Systems Inc., Nix Biosensors, Sonera, Zansors LLC, PointFit Technology Co. Ltd., Bitome Inc., Arma Biosciences, VivaLNK Inc., MC10 Inc., BioIntelliSense Inc.
North America was the largest region in the lab-on-skin microfluidic patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab-on-skin microfluidic patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lab-on-skin microfluidic patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The lab-on-skin microfluidic patch market consists of sales of sensors, microfluidic chips, flexible substrates, electrodes, biosensors, hydrogels, and wearable bands. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lab-On-Skin Microfluidic Patch Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses lab-on-skin microfluidic patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for lab-on-skin microfluidic patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab-on-skin microfluidic patch market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.